Hunting in Packs - Paul Singer -- Catalent (CTLT)
Investing is a lot like fishing or poker -- it takes patience and discipline. I've found that some of my best trades have come about because I did my research early, had conviction, and then entered the terms of my trade in hopes it would be filled when the market met my expectations -- NOT the other way.
My Mansa Musa network often helps to shape my thinking and when we execute trades together or hunt -- we often make money together in business, real estate, investing, etc. When I combine all these concepts or mentalities into one you get the Mansa Musa Mentality. Arguably the richest person in history, Mansa Musa, ruled over a large empire and put cities like Timbuktu on the map as they were known for their cities and libraries.
This posts is an example of how the #MansaMusaMentality work and how I use my extended network to invest. Almost like a case study, I'll highlight how these contacts guide me on investments such as buying real estate, stocks, precious metals, cryptocurrencies, etc. And I want to foster a community culture, so I'll show you how I learn from them and maybe in the future we can crowdsource or here we call it #tribesource investment ideas for the future.
"Detail" - A Breakdown of my Catalent (CTLT) Investment
Research Timetable: July 2023
Research Details:
I read a really good article about Paul Singer, an investor, who is in my Mansa Musa network. Don't believe me just look him up in this 2021 article: URBANOMICS: Mansa Musa Mentality - Building Your Investment Empire
Paul Singer is a hunter, or should I say investor that comes across as shrewd and non-compromising. I started reading articles last year about how he was setting his sights on Catalent. They've had of issues going on:
- Declining business after the COVID-19 pandemic
- Senior Management leaving the company
- FDA notice about cleanliness issues at a facility (a notice or citation is when the regulators find a problem and in healthcare this is bad)
- Left at the Alter - Snubbed by the company Danaher, there was hook up here
- Delayed earnings reports (think about getting your annual checkup, but not wanting to tell anyone)
- Down 50% of their value in since 2022; down 65+% since 2021
- Catalent caved and gave Paul's investment firm four board positions,
- Created a strategic review committee, which usually means they wanna hook up with someone (swipe right)
- They are the primary manufacturer of Novo Nordisk's weight loss drug, Wegovy, and could be a takeover target as companies want to consistent pipeline to deliver these blockbuster drugs
Huntin' In Packs Alert: In August 2023, I decided it was worth riding shotgun with Paul on this one.
The Setup:
Aug 2023: $40
Feb 2024: 2 Trades at the following prices:
- $60
- $56.2691
No comments:
Post a Comment